Overview

Restylane Refyne for Correction of Horizontal Neck Rhytides

Status:
Not yet recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
Subjects with grades ranging from 1--‐3 on the Transverse Neck Line Scale, will be randomized to receive up to 1cc of Restylane Refyne on one side of their neck utilizing a cannula and up to 1cc of Restylane Refyne on the other side utilizing a 30-‐gauge needle. On Day 30, this treatment with the same left--‐right assignment can be repeated if optimal correction on either side has not been achieved according to the treating investigator. Subjects will return 24--48 hours after their first treatment, to fill out questionnaires, take pictures, and to be assessed by blinded evaluators regarding adverse events. Subjects will also return 30 days after their final treatment to fill out final questionnaires, take pictures, and to be assessed by blinded evaluators regarding improvement of static rhytides.
Phase:
Phase 4
Details
Lead Sponsor:
Siperstein Dermatology
Collaborator:
Galderma
Treatments:
Hyaluronic Acid